Followers | 104 |
Posts | 2500 |
Boards Moderated | 0 |
Alias Born | 12/02/2016 |
Sunday, September 10, 2017 4:17:28 PM
I have perused the latest TXTM quarterly report from August 21st, and according to the information found within, we observe that Steve Berman (the current CEO of ONC-I) continues to hold a stake in his former company, Protext Pharma/Mobility.
https://www.otcmarkets.com/financialReportViewersymbol=TXTM&id=177897
According to this filing, Steve Berman maintains beneficial ownership of 2,675,000 Series C Preferred shares. It is also stated that Series C Preferred shares are endowed voting rights equal to 200 votes per each share on all shareholder matters.
As you have alluded, Berman has announced his interest to pursue MJ/Cannabis projects. It is speculative whether Protext will be involved in such future projects, but what does remain clear, is that Berman is most certainly still connected to Protext, as the below information demonstrates.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM